Related Experiment Video

Updated: Oct 11, 2025

Investigating Alterations in Caecum Microbiota After Traumatic Brain Injury in Mice
04:29

Investigating Alterations in Caecum Microbiota After Traumatic Brain Injury in Mice

Published on: September 19, 2019

6.4K

Elderly Patients with Mild Cognitive Impairment Exhibit Altered Gut Microbiota Profiles

Qiong Pan1, Ya-Qian Li2, Ke Guo3

  • 1Department of Obstetrics and Gynecology, The Third Xiangya Hospital of Central South University, Changsha, China.

Journal of Immunology Research
|December 6, 2021
PubMed
Abstract

Insights

Gut microbiota composition differs in mild cognitive impairment (MCI). This study identified specific bacterial species changes in MCI patients, offering potential for early diagnosis and probiotic treatments.

Area of Science:

  • Microbiome research
  • Neuroscience
  • Human health

Background:

  • Mild cognitive impairment (MCI) is a transitional stage between normal aging and Alzheimer's disease.
  • While the gut-brain axis is implicated in Alzheimer's, MCI-specific microbial research is limited.

Purpose of the Study:

  • To investigate differences in gut microbiota composition between individuals with MCI and healthy controls.
  • To identify potential microbial biomarkers for MCI.

Main Methods:

  • Analysis of fecal samples from 48 participants (22 MCI, 26 controls) using 16S rRNA quantitative arrays.
  • Bioinformatics analysis, including Principal Coordinates Analysis (PCoA) and Nonmetric Multidimensional Scaling (NMDS).

Main Results:

  • Gut microbial composition significantly differed between MCI and control groups.
  • Specific bacterial species, such as *Staphylococcus intermedius* and *Bacteroides salyersiae*, were found to be altered in MCI patients.

Conclusions:

  • Gut microbiota composition serves as a distinguishing factor between MCI and healthy individuals.
  • This study presents the first identified gut microbial signature for MCI.
  • Findings suggest potential for early MCI diagnosis and novel probiotic-based therapeutic strategies.

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.1K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.7K

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
23
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
732
What is Monogastric Digestion?01:50

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
72.9K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
538
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
451
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
21